Log In
Print
BCIQ
Print
Print this Print this
 

Nucynta, Nucynta ER, tapentadol ER (CG5503/R331333)

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionExtended-release formulation of mu opioid receptor (MOR) agonist and norepinephrine reuptake inhibitor
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist; Norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$6,300.0M

$3,360.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today